Sentinel lymphonodectomy in gastrointestinal cancer -: Where are we now?

被引:7
作者
Bembenek, A [1 ]
Bayraktar, S [1 ]
Gretschel, S [1 ]
Ulmer, C [1 ]
Schulze, T [1 ]
Markwardt, J [1 ]
Schneider, U [1 ]
Hünerbein, M [1 ]
Schlag, PM [1 ]
机构
[1] Univ Klinikum Charite, Robert Rossle Klin Helios Klinikum Berlin, Berlin, Germany
来源
ONKOLOGIE | 2002年 / 25卷 / 04期
关键词
nodal status; lymph node status; sentinel lymph node; gastrointestinal cancer; colon cancer; rectal cance; gastric cancer; anal cancer;
D O I
10.1159/000066050
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Up to now, no reliable methods for the pre- or intraoperative prediction of the nodal status are available in gastrointestinal cancer patients. Therefore, after the successful application of the sentinel lymph node concept in melanoma and breast cancer, ongoing research on this field is extended to gastrointestinal tumor entities. According to recent experiences, the most promising tumor entities are colon, gastric and anal cancer. First results with these patients indicate that the method could be a reliable predictor of the nodal status and, thus, may have important future implications for adjuvant therapy and the extent of surgery. The dye method for colon cancer and the combined method (dye and radiocolloid) for gastric cancer seem to be appropriate approaches, even when the general experience is still low. In rectal cancer, however, current experience failed yet to yield satisfying results. Up to now, anal cancer has not been a focus of publication, even when the concept seems to be very attractive for the evaluation of the inguinal lymph node status.
引用
收藏
页码:334 / 340
页数:7
相关论文
共 26 条
  • [1] Aikou T, 2001, ANN SURG ONCOL, V8, P90
  • [2] Sentinel lymphadenectomy - Ready for clinical routine?
    Bembenek, A
    Schlag, PM
    [J]. ONKOLOGIE, 2000, 23 (05): : 408 - 409
  • [3] Bembenek A, 1999, Swiss Surg, V5, P217, DOI 10.1024/1023-9332.5.5.217
  • [4] Molecular staging of early colon cancer on the basis of sentinel node analysis: A multicenter phase II trial
    Bilchik, AJ
    Saha, S
    Wiese, D
    Stonecypher, JA
    Wood, TF
    Sostrin, S
    Turner, RR
    Wang, HJ
    Morton, DL
    Hoon, DSB
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) : 1128 - 1136
  • [5] Chin PL, 1999, J SURG ONCOL, V71, P239, DOI 10.1002/(SICI)1096-9098(199908)71:4<239::AID-JSO6>3.0.CO
  • [6] 2-L
  • [7] Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979
  • [8] GRETSCHEL S, 2002, UNPUB CHIRURG
  • [9] CancerVax, an allogeneic tumor cell vaccine, induces specific humoral and cellular immune responses in advanced colon cancer
    Habal, N
    Gupta, RK
    Bilchik, AJ
    Yee, R
    Leopoldo, Z
    Ye, W
    Elashoff, RM
    Morton, DL
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2001, 8 (05) : 389 - 401
  • [10] HERMANEK P, 1995, TUMORI, V81, P60